본문 바로가기

Data Plus(+)

All 807,818 Page 7,712/80,782

검색

Contents

No Journal_name Subject Date DOI Author
730708 FRONTIERS IN ONCOLOGY Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis 2021-08-20 10.3389/fonc.2021.717678 Yang Xue, Li Dongjun, Xie Yao
730707 FRONTIERS IN ONCOLOGY Effect and Safety of Therapeutic Regimens for Patients With Germline BRCA Mutation-Associated Breast Cancer: A Network Meta-Analysis 2021-08-20 10.3389/fonc.2021.718761 Jiang Ying, Meng Xiang-Yu, Deng Ning-Ning, Meng Chen, Li Lu-Hui, He Zi-Kang, Wang Xing-Yun, Song Zhe-Yao, Cui Rong-Jun
730706 FRONTIERS IN ONCOLOGY Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma 2021-08-20 10.3389/fonc.2021.699789 Qian Zenghui, Zhang Lingling, Hu Jie, Chen Shuguang, Chen Hongyan, Shen Huicong, Zheng Fei, Zang Yuying, Chen Xuzhu
730705 FRONTIERS IN ONCOLOGY Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment 2021-08-20 10.3389/fonc.2021.711756 Ma Jing, Han Wei, Lu Kai
730704 FRONTIERS IN ONCOLOGY Prognostic Role of Programmed Death Ligand-1 on Tumor-Infiltrating Immune Cells in “High-Risk” Patients Following Radical Cystectomy: A Retrospective Cohort Study 2021-08-20 10.3389/fonc.2021.706503 Lee Chung Un, Lee Dong Hyeon, Song Wan
730703 FRONTIERS IN ONCOLOGY Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival 2021-08-20 10.3389/fonc.2021.701933 Moriconi Chiara, Civita Prospero, Neto Catia, Pilkington Geoffrey J., Gumbleton Mark
730702 FRONTIERS IN ONCOLOGY Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities? 2021-08-20 10.3389/fonc.2021.730899 Joudinaud Romane, Boyer Thomas
730701 FRONTIERS IN ONCOLOGY Are People With Blood Group O More Susceptible to Nasopharyngeal Carcinoma and Have Worse Survival Rates? A Systematic Review and Meta-Analysis 2021-08-20 10.3389/fonc.2021.698113 Jing Shao-wu, Xu Qing, Zhang Xin-yuan, Jing Zhong-hao, Zhao Zhi-jun, Zhang Ruo-hui, Wu Feng-peng, Wang Jun
730700 FRONTIERS IN ONCOLOGY The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells 2021-08-20 10.3389/fonc.2021.686765 Lu Xiyuan, Han Lina, Busquets Jonathan, Collins Meghan, Lodi Alessia, Marszalek Joseph R., Konopleva Marina, Tiziani Stefano
730699 FRONTIERS IN ONCOLOGY Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers 2021-08-20 10.3389/fonc.2021.674965 Hamdi Yosr, Mighri Najah, Boujemaa Maroua, Mejri Nesrine, Ben Nasr Sonia, Ben Rekaya Mariem, Messaoud Olfa, Bouaziz Hanen, Berrazega Yosra, Rachdi Haifa, Jaidane Olfa, Daoud Nouha, Zribi Aref, Ayari Jihene, El Benna Houda, Labidi Soumaya, Ben Hassouna Jamel, Haddaoui Abderazzek, Rahal Khaled, Benna Farouk, Mrad Ridha, Ben Ahmed Slim, Boussen Hamouda, Boubaker Samir, Abdelhak Sonia